Absence of CD4+ T cells impairs host defence of mice infected with Fonsecaea pedrosoi

Scandinavian Journal of Immunology

Volumn 64, Issue 6, 2006, Pages 595-600

  Teixeira De Sousa, M Da Gloria ^a   Ghosn, E E B ^a   Almeida, S R ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVITY; CHROMOMYCOSIS; COLONY FORMING UNIT; CONTROLLED STUDY; DATA COLLECTION METHOD; DELAYED HYPERSENSITIVITY; DISEASE SEVERITY; EXPERIMENTAL INFECTION; EXPERIMENTAL MODEL; FEMALE; FONSECAEA PEDROSOI; FUNGUS IMMUNITY; HOST RESISTANCE; IMMUNE DEFICIENCY; INTERFERON PRODUCTION; LYMPHOCYTE FUNCTION; MOUSE; MYCOSIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; ASCOMYCOTA; BIOLOGICAL ASSAY; CD4-POSITIVE T-LYMPHOCYTES; CHROMOBLASTOMYCOSIS; HYPERSENSITIVITY, DELAYED; INTERFERON TYPE II; LYMPHOCYTE DEPLETION; MICE; MICE, MUTANT STRAINS;

EID: 33750694209     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2006.01846.x     Document Type: Article

References (30)

1. Londero AT, Ramos CD. Chromomycosis. A clinical and mycological study of 35 cases observed in the hinterland of Rio Grande do Sul, Brazil. Am J Trop Med Hyg 1976;25:132-5.
2. McGinnis MR, Ajello L, Schell MS. Mycotic diseases. A proposed nomenclature. Int J Dermatol 1985;24:9-15.
3. Rippon JW. Chromoblastomycosis. In: Rippon JW, ed. Medical Mycology. The Pathogenic Fungi and the Pathogenic Actinomycetes. Philadelphia, PA: WB Saunders, 1988:276-98.
4. Brandt ME, Warnock DW. Epidemiology, clinical manifestations, and therapy infections caused by dematiaceous fungi. J Chemother 2003;15:36-47.
5. Esterre P, Jahevitra M, Andriantsimahavandy A. Humoral immune response in chromoblastomycosis during and after therapy. Clin Diag Lab Immunol 2000;7:497-500.
6. Kurita N. Cell mediated immune responses in mice infected with Fonsecaea pedrosoi. Mycopathologia 1979;68:9-12.
7. D'Avila SC, Pagliari C, Duarte MI. The cell-mediated immune reaction in the cutaneous lesion of chromoblastomycosis and their correlation with different clinical forms of the disease. Mycopathologia 2003;156:51-60.
8. Rozental S, Alviano CS, de Souza W. The in vitro susceptibility of Fonsecaea pedrosoi to activated macrophages. Mycopathologia 1994;126:85-91.
9. Rozental S, Alviano CS, de Souza W. Fine structure and cytochemistry of the interaction between Fonsecaea pedrosoi and mouse resident macrophages. J Med Vet Mycol 1996;28:373-83.
10. Alviano DS, Franzen AJ, Travassos LR, Holandino C, Rozental S, Ejzemberg R, Alviano CS, Rodrigues ML. Melanin from Fonsecaea pedrosoi induces production of human antifungal antibodies and inhances the antimicrobial efficacy of phagocytes. Infect Immun 2004;72:229-37.
11. Ahrens J, Graybill JR, Abishawl A, Tio FO, Rinaldi MG. Experimental murine chromomycosis mimicking chronic progressive human disease. Am J Trop Med Hyg 1989;40:651-8.
12. Gimenes VMF, Sousa MG, Ferreira KS et al. Cytokine and lymphocyte proliferation in patients with different clinical forms of chromoblastomycosis. Microbes Infec 2005;7:708-13.
13. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein resing the principle of protein-dye binding. Anal Biochem 1976;72:248-59.
14. + T cells. J Exp Med 1991;173:793-800.
15. Jiang C, Magee DM, Cox R. Coadministration of interleukin-12 expression vector with antigen 2 cDNA enhances induction of protective immunity against Coccidioides immitis. Infect Immun 1999;67:5848-53.
16. Kashino SS, Fazioli RA, Cafalli-Favati C et al. Resistance to Paracoccidiodes brasiliensis infection is linked to a preferential Th1 immune response whereas susceptibility is associated with absence of IFN-γ production. J Interferon Cytokine Res 2000;20:89-97.
17. + T cells in host resistance to systemic infection with Histoplasma capsulatum in mice. J Immunol 1994;152:3491-500.
18. Cassone A. Cell-mediated immunity mechanisms in fungal infection. In: Murphy JW, Friedman H, Bendinelli M, eds. Fungal Infections and Immune Responses. New York: Plenum Press, 1993:113-35.
19. + T cells and macrophages in acquired protection against infection with Sporothrix schenckii in mice. Med Mycol 1999;37:397-401.
20. + T cell subset selection in mice with candidiasis. J Immunol 1997;158:3356-62.
21. + T cells following secondary infection of mice immune to Leishmania major. Infect Immun 1994;62:2575-81.
22. + monoclonal antibodies on Mycobacterium paratuberculosis infection in intragastrically challenged mice. Immunol Lett 1993;35:183-90.
23. Cano LE, Singer-Vermes LM, Mengel JA et al. Depletion of CD8 T cells in vivo impairs host defense of resistant and susceptible mice to pulmonary paracoccidioidomycosis. Infect Immun 2000;68:352-9.
24. Bocca AL, Brito PP, Figueiredo F, Tosta CE. Inhibition of nitric oxide production by macrophages in chromoblastomycosis: a role for Fonsecaea pedrosoi melanin. Mycopathologia 2006;161:195-203.
25. Issekuts TB, Stoltz JM, Van der Meide P. Lymphocyte recruitment in delayed-type hypersensitivity. The role of IFN-gamma. J Immunol 1988;140:2989-93.
26. Pober JS, Gimbrone MA, LaPierre LA Jr, Mendrick DL, Fiers W, Rothlein R, Springer TA. Overlapping patterns of activation of human endothelial cells by interleukin-1, tumor necrosis factor and immune interferon. J Immunol 1986;137:1893-9.
27. Salkowski CA, Balish E. A monoclonal antibody to gamma interferon blocks augmentation of natural killer cell activity induced during systemic cryptococcosis. Infect Immun 1991;59:486-93.
28. Ulrichs T, Munk ME, Mollenkopf H et al. Differential T cell responses to Mycobacterium tuberculosis ESAT-6 in tuberculosis patients and healthy donors. Eur J Immunol 1998;28:3949-58.
29. Yamamura M, Uyemura K, Deans RJ et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991;254:277-9.
30. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J Exp Med 1989;169:59-72.